Status | Study |
Not yet recruiting |
Study Name: Study in Subjects With Light Chain (AL) Amyloidosis Condition: AL Amyloidosis Date: 2017-04-28 Interventions: Drug: NEOD001 humanized monoclonal antibody |
Not yet recruiting |
Study Name: Renal AL Amyloid Involvement and NEOD001 Condition: Amyloidosis Date: 2017-04-26 Interventions: Drug: NEOD001 NEOD001 is a mon |
Not yet recruiting |
Study Name: Ibrutinib With or Without Bortezomib and Dexamethasone in Treating Patients With Relapsed or Refractory Immunoglobulin Light Chain Amyloidosis Condition: Amyloidosis Immunoglobulin Light Chain Deposition Date: 2017-04-21 Interventions: Drug: Bortezomib Given SC |
Enrolling by invitation |
Study Name: Return of Amyloid Imaging Results (Result Study) Condition: Mild Cognitive Impairment Date: 2017-04-14 Interventions: Other: Scan Opportunity Participants in the scan group are provided the option of having an amyloid PET |
Recruiting |
Study Name: PET/MRI Evaluation of Cardiac Amyloid Condition: Cardiac Amyloidosis Date: 2017-04-13 Interventions: Diagnostic Test: 18F‑Florbetaben (Neuraceq®) PET/MRI Administration of 8.0 mCi 18F‑Flor |
Not yet recruiting |
Study Name: A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease Condition: Alzheimer's Disease Date: 2017-04-05 Interventions: Drug: CNP520 50mg Arm#1 |
Not yet recruiting |
Study Name: Radioisotope Scintigraphy to Establish Incidence of Cardiac Amyloidosis Among Patients With Otherwise Unexplained Cardiac Disease Condition: Cardiac TTR Amyloidosis Date: 2017-03-28 Interventions: Diagnostic Test: Tc99m-labeled pyrophosphate scan Intravenous injection of Tc99m-labeled pyrophosphate w |
Recruiting |
Study Name: Cognitive Function and Prevalence of Amyloid Marker in Frail Older Adults Condition: Frail Elderly Date: 2017-03-02 Interventions: Procedure: MRI and PET scan Neuroimaging with MRI and PET scan Amyloid tracer : For PET-scans, 4 MBq/kg |
Recruiting |
Study Name: APOE Genotype and Diet Influences on Alzheimer's Biomarkers Condition: Alzheimer's Disease; Dementia Date: 2017-02-27 Interventions: Other: HIGH and LOW meal ingestion The study will examine CSF biomarker responses to HIGH and LOW meals |
Recruiting |
Study Name: Blood Brain Barrier Opening in Alzheimer' Disease Condition: Alzheimer Disease Date: 2017-02-27 Interventions: Device: SONOCLOUD® BBB opening by ultrasound Ot |